Non-invasive assessment of liver fi brosis: Are we ready?

The Lancet

Volumn 375, Issue 9724, 2010, Pages 1419-1420

  Castera, Laurent ^a   Pinzani, Massimo ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BIOLOGICAL MARKER;

ALCOHOLIC FATTY LIVER; ANTIVIRAL THERAPY; AREA UNDER THE CURVE; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELASTOGRAPHY; HEPATITIS; HISTOPATHOLOGY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; NOTE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; STANDARD; THROMBOCYTE; VALIDATION PROCESS; ARTICLE; BLOOD; HUMAN; THROMBOCYTE COUNT;

ASPARTIC ACID; BIOLOGICAL MARKERS; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER CIRRHOSIS; PLATELET COUNT;

EID: 77952305743     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62195-4     Document Type: Note

References (12)

1. Pinzani M, Vizzutti F, Arena U, Marra F. Technology insight: noninvasive assessment of liver fi brosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008;5:95-106.
2. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fi brosis using transient elastography. J Hepatol 2008;48:835-47.
3. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fi brosis: a meta-analysis. Gastroenterology 2008;134:960-74.
4. Poynard T, Morra R, Halfon P, et al. Meta-analyses of Fibrotest diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40.
5. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fi brosis: a systematic review. Hepatology 2007;46:912-21.
6. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fi brosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
7. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiff ness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-97.
8. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-08.
9. Hézode C, Castéra L, Roudot-Thoraval F, et al. Prospective evaluation of liver stiff ness dynamics during and after peginterferon alpha-ribavirin treatment in patients with chronic hepatitis C. J Hepatol 2009;50 (suppl 1): S226 (abstr).
10. WHO. Mortality database 2006. http://www.who.int/healthinfo/morttables/ en/index.html (accessed Dec. 1, 2009).
11. Poynard T, Lebray P, Ingiliz P, et al. Screening for liver advanced fi brosis using non-invasive biomarker Fibrotest in general population. J Hepatol 2009;50 (suppl 1): S369 (abstr).
12. Roulot D, Buyck JF, Gambier N, et al. Liver stiff ness measurement: an appropriate screening method to detect liver fi brosis in the general population. J Hepatol 2009;50 (suppl 1): S89 (abstr).